ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Psychopharmacology

Apps, Efficacy, Adherence—and MDD

The latest news on the treatment of depression covers patient self-management apps, antidepressant efficacy in older adults, and strategies to improve adherence. ©Lightspring/ Shutterstock

Related content:
MDD: Closing in on the Right Drug at the Right Dose

Psychopharmacology

New evidence bolsters the reputation of clozapine as the “gold-standard” antipsychotic for patients with treatment-resistant schizophrenia.

©eldar nurkovic/shutterstock.com

The authors outline a series of strategies that can help promote adherence to the therapeutic regimen.

Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.

Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?

SaimonSailent-Shutterstock

This article delineates the role of psychiatrists in preventing HIV transmission before and after HIV exposure through pre- and post-exposure prophylaxis.

© ICEDMOCHA/SHUTTERSTOCK.COM

Neither time nor science has given pause to some attorneys who exploit the misunderstanding that surrounds the putative "criminogenic" effects of antidepressants.

© Lightspring/shutterstock.com

This article focuses on appropriate versus inappropriate use of antipsychotics, the importance of careful assessment, and the consequences of not treating.

Pages

Subscribe to Psychopharmacology on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.